Additionally, CCL5 is highly expressed in advanced triple‐negative breast cancer,174 whereas CCL5 is not overexpressed in breast tissue from women with benign breast disease or those who have undergone breast reduction.168. The gene discussed is CCL5; the disease is breast fibrocystic disease.